Sagimet Biosciences (SGMT) Total Non-Current Liabilities (2022 - 2023)
Sagimet Biosciences (SGMT) reported Total Non-Current Liabilities of $5.05 million for Q3 2023.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Total Non-Current Liabilities (2022 - 2023) Analysis & Trends
At the end of FY2022, Sagimet Biosciences posted Total Non-Current Liabilities of $219.98 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Sagimet Biosciences | 569.92 Mn | -4.57 Mn | - | - |
API Access
Sagimet Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();